Personalized Medicine and Nanotechnology: Transforming Modern Therapeutics

The new trend in the shape of nanotechnology is, however, very lately revolutionizing modern drug delivery to the target sites by very sophisticated nanocarriers. Nano scale vehicles confer solubility and, accordingly, the possible level of bioavailability may relate to the promised assurance of the targeted therapy. Nanocarrier-based present delivery mechanisms form some of it in the mode of liposomes, nanoparticles, proniosomes, etc. Among them, PEGylation and receptormediated targeting by liposome technology improve its efficiency and circulation time in the blood. Liposomal inhalation therapy, chewable tablets, and mouth-dissolving films will further increase the patient-friendly route of administration. Proniosomes are stable and scalable alternatives to liposomes with enhanced drug retention. Hybrid nanocarrier systems-once combining vesicular and non-vesicular approaches-further refine controlled release and multifunctional therapeutic strategies. Liposomal antibiotics provide answers to the problems of antibiotic resistance; nanocarrier-based herbal drug formulations would improve bioavailability. Clinical translation, however remains a tough challenge ahead to progress in these areas for improvement in biocompatibility, scalability, and regulatory compliance, so the above trends would focus the future more on AI-driven nanomedicine, stimuli-responsive carriers, gene-editing nanotechnology, even biomimetic drug transport systems for precision targeted and patient-specific therapeutics. This review should describe the present landscape of development and challenges within the convergence of nanotechnology with personalized medicine for transformative applications.